Dr. Jatin Shah received his medical degree from Ohio State University College of Medicine, Columbus, Ohio. He completed an internship and residency in internal medicine at the Cleveland Clinic Foundation, Cleveland, Ohio, and a fellowship in hematology/oncology at the University of Alabama at Birmingham. Dr. Shah is an associate professor and associate program director of the malignant hematology fellowship, as well as director of myeloma clinical and translational research in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, Houston.

Dr. Shah holds board certification in hematology and oncology from the American Board of Internal Medicine. He is a member of the American Medical Association, American College of Physicians-American Society of Internal Medicine, American Society of Clinical Oncology, American Society of Hematology, American Association of Cancer Research, SWOG, and the International Myeloma Working Group. Dr. Shah is currently a reviewer for the British Journal of Haematology, Cancer, Leukemia, and The Oncologist. In addition he isprincipal investigator/co-investigator for numerous relapsed/refractory multiple myeloma studies and has published articles and abstracts in many peer-reviewed journals.